331 results on '"Faraci, M"'
Search Results
2. ‘Real-life’ report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO)
3. Fertility preservation practices in pediatric and adolescent cancer patients undergoing HSCT in Europe: a population-based survey
4. Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters
5. Paediatric reduced intensity conditioning: analysis of centre strategies on regimens and definitions by the EBMT Paediatric Diseases and Complications and Quality of Life WP
6. Persistence of high-level (1,3)-β-D-glucan after candidemia following autologous peripheral SCT in a pediatric patient
7. Relationship between clinical and BK virological response in patients with late hemorrhagic cystitis treated with cidofovir: a retrospective study from the European Group for Blood and Marrow Transplantation
8. Viral-load and B-lymphocyte monitoring of EBV reactivation after allogeneic hemopoietic SCT in children
9. ALLOGENEIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH ADVANCED RHABDOMYOSARCOMA: A RETROSPECTIVE ASSESSMENT: PH-AB118
10. ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CONGENITAL DISORDERS. A SINGLE CENTRE EXPERIENCE: PH-P563
11. ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CONGENITAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: 17-YEARS SINGLE PEDIATRIC CENTRE EXPERIENCE: PH-P565
12. STEM CELL TRANSPLANTATION FOR CML IN CHILDREN AND ADOLESCENTS FOLLOWING REDUCED INTENSITY CONDITIONING - AN ALTERNATIVE TO LIFE-LONG TKIS?: PH-P089
13. Daclizumab as useful treatment in refractory acute GVHD: a paediatric experience
14. Assessing the risk of transplant-related complications and individually tailoring the HSCT procedure in children and adolescents—is it possible?
15. Prospective single-arm study of pegfilgrastim activity and safety in children with poor-risk malignant tumours receiving chemotherapy
16. Invasive mycoses in children receiving hemopoietic SCT
17. Non-endocrine late complications in children after allogeneic haematopoietic SCT
18. Prevention and treatment of acute GvHD
19. Endocrinological late complications after hematopoietic SCT in children
20. Rare viral infections in children receiving hemopoietic stem cell transplant
21. Early complications following haematopoietic SCT in children
22. Incidence of bacteremias and invasive mycoses in children undergoing allogeneic hematopoietic stem cell transplantation: a single center experience
23. Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties
24. Exercise capacity in apparently healthy survivors of cancer
25. Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: a survey from the Italian association of pediatric hematology oncology–bone marrow transplantation group
26. Mesial temporal sclerosis – a late complication in four allogeneic pediatric recipients with persistent seizures after an acute episode of cyclosporine-A neurotoxicity
27. Autoimmune haematological diseases after allogeneic haematopoietic stem cell transplantation in children. Italian multicentre experience: O166
28. Long-term follow-up of two children with a variant of mild autosomal recessive osteopetrosis undergoing bone marrow transplantation
29. Bacteraemias and invasive fungal disease infection in children with acute GvHD. A single-centre experience: P806
30. Treosulphan as an effective and safe chemotherapeutic drug in preparative regimen for allogeneic haematopoietic stem cell transplantation. A paediatric single-centre experience: 680
31. Incidence and risk factors for secondary autoimmune diseases after cord blood transplantation. Retrospective analysis on behalf of Eurocord and the EBMT Working Party Autoimmune Diseases: O179
32. Bacteremias and invasive fungal diseases in children receiving etanercept for steroid-resistant acute GVHD
33. Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation
34. SCT for Wilms’ tumour
35. Bacteremias in children receiving hemopoietic SCT
36. Hepatitis B reactivation in allogeneic hemopoietic stem cell transplantation setting: A pediatric experience
37. The long-term effect of pubertal development on bone mineral density in patients who underwent HSCT during childhood: O177
38. Allogeneic bone marrow transplantation for Pearson's syndrome
39. A retrospective EBMT survey on the use of cidofovir for BK-related haemorrhagic cystitis after allogeneic haematopoietic stem cell transplant
40. Nitazoxanide or CD3+/CD4+ lymphocytes for recovery from severe Cryptosporidium infection after allogeneic bone marrow transplant?
41. Sporicidal action of peracetic acid and protective effects of transition metal ions
42. Arthrogryposis, renal dysfunction and cholestasis syndrome: Report of five patients from three Italian families
43. Cardiac and pulmonary function late effects after bone marrow transplantation in childhood: prospective study on behalf of EBMT LEWP Group
44. Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant
45. Pregnancy and pregnancy outcomes after hematopoietic stem cell transplantation in childhood: a cross-sectional survey of the EBMT Pediatric Diseases Working Party.
46. Preliminary results of psycho-diagnostic evaluation in adolescents who received SCT in paediatric age
47. Avascular necrosis after allogeneic SCT in childhood. Description of cases enrolled in a case-control study in Italy
48. Results of a prospective study on central nervous system complications following BMT/SCT by the EBMT-IDWP
49. Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment.
50. Invasive mycoses in children receiving hemopoietic SCT.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.